PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
Recruiting now
Conditions studied: End Stage Renal Disease, Hemodialysis Access Failure
In brief
The goal of this observational study is to increase the understanding of the safety and performance of Merit Medical's HeRO Graft System (HeRO) and Super HeRO Adaptor and Support Seal System (Super HeRO) devices. This study includes adults that are being treated with one of these devices as part of their regular medical care for maintaining long-term dialysis access when all other dialysis access options have failed. If participants in the study are not seen for a standard of care clinic visit during the 4 visit timepoints over 2 years, the participant will be followed by phone to check their current health and dialysis status.
Key facts
- Study ID
- NCT06422871
- Run by
- Merit Medical Systems, Inc.
- People needed
- 100
- Starts
- 2025-07-28
- Expected to finish
- 2028-12-28
- Last updated by the study team
- 2026-06-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- MedStar Washington Hospital Center — Washington D.C., District of Columbia, United States (enrolling)
- Sarasota Memorial Health Care System — Sarasota, Florida, United States (enrolling)
- WakeMed — Raleigh, North Carolina, United States (enrolling)
- University Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States (enrolling)
- Baylor Scott & White Heart and Vascular Hospital - Dallas — Dallas, Texas, United States (enrolling)
- Houston Methodist Hospital — Houston, Texas, United States (enrolling)
- Sentara Norfolk General Hospital — Norfolk, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.